chartexchange

VOR
Vor Biopharma Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:53 PM EST
17.83USD-1.925%(-0.35)794,108
Pre-marketNov 18, 2026 9:06:30 AM EST
18.00USD-0.990%(-0.18)
After-hoursNov 18, 2026 4:27:30 PM EST
17.83USD0.000%(0.00)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Cambridge, MA, USA
Previous Close
$18.18
Beta
1.71
52-Week High
$26.00 2026-09-08
52-Week Low
$6.50 2025-11-20
SMA 50
$19.62
SMA 200
$17.61
Avg. Vol 10D
702,100
Avg. Vol 30D
780,580
Avg. Vol 90D
901,703
Relative Vol
1.02
35.67M
0.4200%
1,800,000
70,195
Sep 19, 2025 · 1-for-20 (reverse)
VOR Profile

vor biopharma is pioneering engineered hematopoietic stem cells (ehscs) to dramatically change the treatment paradigm for hematological cancers. vor's ehscs are designed to generate healthy, fully functional cells with specific advantageous modifications, for example to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from depletion but leaving tumor cells vulnerable. vor's platform could potentially be used to change the treatment paradigm of both hematopoietic stem cell transplants and antigen-targeted therapies such as antibody drug conjugates, bispecific antibodies and car-t cell treatments. a proof-of-concept study for vor's lead program has been published in proceedings of the national academy of sciences. vor is based in cambridge, mass. and has a broad intellectual property base including in-licenses from columbia university, where foundational work was conducted by inventor and vor scientific board chair siddhar

VOR Performance
PeriodPriceDateChangeBeta
1W19.322026-11-12-7.66%1.172
1M18.042026-10-19-1.11%1.821
3M23.582026-08-19-24.34%1.914
6M14.132026-05-19+26.26%1.970
1Y7.822025-11-19+128.13%1.709
2Y15.302024-11-19+16.57%—
5Y271.602021-11-19-93.43%1.258
VOR Stock Summary

Vor Biopharma Inc. Common Stock (NASDAQ:VOR) stock price today is $17.84, and today's volume is 794,108. VOR is down 1.870% today. The 30 day average volume is 780,580. VOR market cap is $1.10B with 61.43M shares outstanding.